These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

306 related articles for article (PubMed ID: 15251933)

  • 1. Challenges for biomarkers in cancer detection.
    Wagner PD; Verma M; Srivastava S
    Ann N Y Acad Sci; 2004 Jun; 1022():9-16. PubMed ID: 15251933
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Use of DNA methylation for cancer detection: promises and challenges.
    Zhu J; Yao X
    Int J Biochem Cell Biol; 2009 Jan; 41(1):147-54. PubMed ID: 18834953
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The footprints of cancer development: Cancer biomarkers.
    Ullah MF; Aatif M
    Cancer Treat Rev; 2009 May; 35(3):193-200. PubMed ID: 19062197
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Biomarkers for lung cancer: clinical uses.
    Greenberg AK; Lee MS
    Curr Opin Pulm Med; 2007 Jul; 13(4):249-55. PubMed ID: 17534168
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Advances in ovarian cancer proteomics: the quest for biomarkers and improved therapeutic interventions.
    Jurisicova A; Jurisica I; Kislinger T
    Expert Rev Proteomics; 2008 Aug; 5(4):551-60. PubMed ID: 18761466
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Proteomic approaches in lung cancer biomarker development.
    Cho JY; Sung HJ
    Expert Rev Proteomics; 2009 Feb; 6(1):27-42. PubMed ID: 19210125
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Challenges in cancer research and multifaceted approaches for cancer biomarker quest.
    Martinkova J; Gadher SJ; Hajduch M; Kovarova H
    FEBS Lett; 2009 Jun; 583(11):1772-84. PubMed ID: 19327356
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Biomarker assay translation from discovery to clinical studies in cancer drug development: quantification of emerging protein biomarkers.
    Lee JW; Figeys D; Vasilescu J
    Adv Cancer Res; 2007; 96():269-98. PubMed ID: 17161683
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Perspectives of clinical proteomics in gastrointestinal cancer.
    Ebert M; Xing X; Burgermeister E; Schmid R; Röcken C
    Expert Rev Anticancer Ther; 2007 Apr; 7(4):465-9. PubMed ID: 17428167
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Biomarker discovery in lung cancer--promises and challenges of clinical proteomics.
    Bharti A; Ma PC; Salgia R
    Mass Spectrom Rev; 2007; 26(3):451-66. PubMed ID: 17407130
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Strategies for discovering novel cancer biomarkers through utilization of emerging technologies.
    Kulasingam V; Diamandis EP
    Nat Clin Pract Oncol; 2008 Oct; 5(10):588-99. PubMed ID: 18695711
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [The use of biomarkers in cancer prevention].
    Tompa A
    Orv Hetil; 2006 Apr; 147(14):627-36. PubMed ID: 16711369
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Monitoring of human populations for early markers of cadmium toxicity: a review.
    Fowler BA
    Toxicol Appl Pharmacol; 2009 Aug; 238(3):294-300. PubMed ID: 19433102
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Proteome informatics for cancer research: from molecules to clinic.
    Brusic V; Marina O; Wu CJ; Reinherz EL
    Proteomics; 2007 Mar; 7(6):976-91. PubMed ID: 17370257
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Toward the discovery of new biomarkers of hepatocellular carcinoma by proteomics.
    Santamaría E; Muñoz J; Fernández-Irigoyen J; Prìeto J; Corrales FJ
    Liver Int; 2007 Mar; 27(2):163-73. PubMed ID: 17311610
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Advances, challenges, and limitations in serum-proteome-based cancer diagnosis.
    Ebert MP; Korc M; Malfertheiner P; Röcken C
    J Proteome Res; 2006 Jan; 5(1):19-25. PubMed ID: 16396491
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cancer biomarkers--an invitation to the table.
    Dalton WS; Friend SH
    Science; 2006 May; 312(5777):1165-8. PubMed ID: 16728629
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Proteomic profiling: the potential of Seldi-Tof for the identification of new cancer biomarkers].
    Solassol J; Marin P; Maudelonde T; Mangé A
    Bull Cancer; 2005 Sep; 92(9):763-8. PubMed ID: 16203265
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Recent advances in biomarkers for cancer diagnosis and treatment.
    Manne U; Srivastava RG; Srivastava S
    Drug Discov Today; 2005 Jul; 10(14):965-76. PubMed ID: 16023055
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Quantitation of promoter methylation of multiple genes in urine DNA and bladder cancer detection.
    Hoque MO; Begum S; Topaloglu O; Chatterjee A; Rosenbaum E; Van Criekinge W; Westra WH; Schoenberg M; Zahurak M; Goodman SN; Sidransky D
    J Natl Cancer Inst; 2006 Jul; 98(14):996-1004. PubMed ID: 16849682
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.